← Insider buys
CUE

Cue Biopharma, Inc. · Healthcare

Director Christopher A Marlett bought $86K of Cue Biopharma, Inc.

Bought$85,937
$4.64Price
18,521Shares
+2%Stake

What CUE did for a copier

Prices for CUE after this filing aren't in yet.

Christopher A Marlett's record

9 other buys on record. A record shows here once 3 of them have 3 months of prices.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Mon, Dec 31. Filed Wed, Jan 2, 4:20 PM ET, after the close. Not investment advice.